According to Stratistics MRC, the Global Stents Market is valued at $8.43 billion in 2015 and is projected to reach $12.13 billion by 2022 growing at a Compound Annual Growth Rate of 5.3%. Rising adoption of drug-eluting stents as a more efficient treatment for coronary heart disease, coupled with growing awareness among patients about stents, is anticipated to fuel the market growth. On the other hand strict regulations for approval of stents, abridged reimbursement and substitute methods are hampering the market. The innovation of technological advanced products with lower re-stenosis occurrence rates such as bio-absorbable stents and the existence of high unmet medical needs in emerging Asian countries are some of the future growth opportunities of this market.